The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Management and outcomes of patients with renal medullary carcinoma (RMC): A collaborative multi-center study of 52 patients.
 
Amishi Yogesh Shah
No Relationships to Disclose
 
Jose A. Karam
No Relationships to Disclose
 
Gabriel G. Malouf
Honoraria - GlaxoSmithKline; Janssen; Novartis; Roche
Consulting or Advisory Role - Novartis
Research Funding - Novartis; Pfizer
Travel, Accommodations, Expenses - Amgen; Janssen; Novartis; Pfizer
 
Priya Rao
No Relationships to Disclose
 
Zita Dubauskas Lim
No Relationships to Disclose
 
Eric Jonasch
No Relationships to Disclose
 
Lianchun Xiao
No Relationships to Disclose
 
Jianjun Gao
No Relationships to Disclose
 
Ulka N. Vaishampayan
Honoraria - Astellas Pharma; Bayer; Janssen; Novartis; Pfizer; Sanofi
Consulting or Advisory Role - Astellas Pharma; Bristol-Myers Squibb; Novartis; Pfizer; Sanofi
Speakers' Bureau - Astellas Pharma; Bayer; Janssen; Novartis; Pfizer
Research Funding - Astellas Pharma; Exelixis; Novartis; Pfizer
 
Daniel Yick Chin Heng
Consulting or Advisory Role - Astellas Pharma; Bristol-Myers Squibb; Janssen; Novartis; Pfizer
 
Elizabeth R. Plimack
Consulting or Advisory Role - Acceleron Pharma; Bristol-Myers Squibb; Dendreon; Genentech/Roche; GlaxoSmithKline; Merck; Novartis; Pfizer
Research Funding - Acceleron Pharma (Inst); Acerta Pharma (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Dendreon (Inst); GlaxoSmithKline (Inst); Lilly (Inst); Merck (Inst); Pfizer (Inst)
Patents, Royalties, Other Intellectual Property - U.S. Patent No.: 14/588,503, Filed 1/2/2015. (Inst)
 
Elizabeth A. Guancial
No Relationships to Disclose
 
Chunkit Fung
Stock and Other Ownership Interests - GlaxoSmithKline
Consulting or Advisory Role - Bayer; Dendreon; Janssen Scientific Affairs
Research Funding - Astellas Pharma (Inst)
 
Stefanie Rose Lowas
No Relationships to Disclose
 
Pheroze Tamboli
No Relationships to Disclose
 
Kanishka Sircar
No Relationships to Disclose
 
Surena F. Matin
Consulting or Advisory Role - Theracoat; Tokai Pharmaceuticals
Research Funding - AT&T
 
Kimryn Rathmell
Research Funding - GlaxoSmithKline
Travel, Accommodations, Expenses - Novartis
Other Relationship - Novartis (I)
 
Christopher G. Wood
Consulting or Advisory Role - Ono Pharmaceutical
Research Funding - Argos Therapeutics; Boehringer Ingelheim; GlaxoSmithKline; Ono Pharmaceutical; Pfizer
Travel, Accommodations, Expenses - Argos Therapeutics
 
Nizar M. Tannir
Honoraria - Bristol-Myers Squibb; Exelixis; GlaxoSmithKline; Nektar; Novartis; Pfizer
Consulting or Advisory Role - Bristol-Myers Squibb; Exelixis; GlaxoSmithKline; Nektar; Novartis
Research Funding - Bristol-Myers Squibb; Epizyme; Exelixis; Novartis
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Exelixis; GlaxoSmithKline; Nektar; Novartis; Pfizer